Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Karel Krejčí"'
Autor:
Dana Thomasová, Michaela Zelinová, Malgorzata Libik, Jan Geryk, Pavel Votýpka, Silvie Rajnochová Bloudíčková, Karel Krejčí, Jana Reiterová, Eva Jančová, Jana Machová, Martina Kollárová, Ivan Rychík, Martin Havrda, Miroslava Horáčková, Martina Putzová, Roman Šafránek, Marek Kollár, Milan Macek
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundGenetic focal segmental glomerulosclerosis (FSGS) is caused by pathogenic variants in a broad spectrum of genes that have a variable representation based on subjects' ethnicity and/or age. The most frequently mutated autosomal recessive gen
Externí odkaz:
https://doaj.org/article/479ea1a14e1744f48660a15eb5b738b1
Autor:
Ester Kurašová, Jakub Štěpán, Karel Krejčí, František Mrázek, Pavel Sauer, Jana Janečková, Tomáš Tichý
Publikováno v:
Acta Medica, Vol 65, Iss 4, Pp 119-124 (2023)
All renal transplant recipients should undergo a regular screening for BK viral (BKV) viremia. Gradual reduction of immunosuppression is recommended in patients with persistent plasma BKV viremia for 3 weeks after the first detection, reflecting the
Externí odkaz:
https://doaj.org/article/5e6d7455b61241cdb6f1887a5479824e
Autor:
Ester Kurašová, Jakub Štěpán, Karel Krejčí, František Mrázek, Pavel Sauer, Jana Janečková, Tomáš Tichý
Publikováno v:
Acta Medica (Hradec Kralove, Czech Republic). 65:119-124
All renal transplant recipients should undergo a regular screening for BK viral (BKV) viremia. Gradual reduction of immunosuppression is recommended in patients with persistent plasma BKV viremia for 3 weeks after the first detection, reflecting the
Autor:
Pavel Zemla, Igor Hartmann, Frantisek Hruska, Milan Kral, Jana Janeckova, Petr Utikal, Ales Vidlar, Karel Krejcí, Petr Bachleda
Publikováno v:
Biomedical Papers, Vol 168, Iss 2, Pp 177-180 (2024)
Introduction. A kidney transplant is the best method for treating terminal kidney failure. Long-term results of kidney transplants from living donors are significantly better than transplants from dead donors. Living kidney donors are healthy people
Externí odkaz:
https://doaj.org/article/4616ce8dd82242368319cbd4a1c42b30
Autor:
Tomáš Tichý, Josef Zadražil, Jana Bednaříková, Jiří Orság, Karel Krejčí, Kamil Žamboch, Margita Bartková
Publikováno v:
Journal of Medical Virology. 93:3871-3879
BK polyomavirus-associated nephropathy (PyVAN) is responsible for a significant percentage of transplanted kidneys prematurely terminating their function. Its occurrence is closely related to the intensity of immunosuppressive therapy. In a group of
Autor:
Eva Pokorna, Marek Kollar, Roman Safranek, Jakub Zieg, Jana Machova, Vojtech Petr, Karel Krejčí, Ondrej Viklicky, Sona Stepankova, Jarmila Dedochova, Petra Hruba, Janka Slatinska
Publikováno v:
Transplantation Direct, Vol 7, Iss 11, p e779 (2021)
Transplantation Direct
Transplantation Direct
Supplemental Digital Content is available in the text.
Background. Thrombotic microangiopathy (TMA) significantly affects kidney graft survival, but its pathophysiology remains poorly understood. Methods. In this multicenter, retrospective, case
Background. Thrombotic microangiopathy (TMA) significantly affects kidney graft survival, but its pathophysiology remains poorly understood. Methods. In this multicenter, retrospective, case
Autor:
Karel Krejčí, Tomáš Tichý, Pavel Sauer, Josef Zadražil, Ester Kurašová, Jakub Štěpán, Kamil Žamboch, Jiří Orság, František Mrázek
Publikováno v:
Transplantation. 106:S615-S615
Autor:
Jana Bednaříková, Jiří Orság, Karel Krejčí, Josef Zadražil, František Mrázek, Tomáš Tichý, Kamil Žamboch, Margita Bartková
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims BK virus nephropathy (BKVN) represents a serious complication of kidney transplantation and is responsible for significant percentage of transplanted kidneys prematurely terminating their function. Its occurrence is considered a c
Autor:
Karel Krejčí, Roman Safranek, Ondrej Viklicky, Jarmila Dedochova, Sona Stepankova, Marek Kollar, Vojtěch Petr, Jana Machova, Petra Hruba, Janka Slatinska, Eva Honsova, Sylvie Dusilova Sulkova
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Thrombotic microangiopathy (TMA) pathogenesis in kidney transplantation is poorly understood. The aim of this study was to evaluate donor and recipients risk factors for posttransplant TMA. Method In this retrospective multicenter
Publikováno v:
Klinická farmakologie a farmacie. 31:3-6
Aims: Tacrolimus is the mainstay of transplant immunosuppression in kidney graft recipients. It is most commonly used in combinationwith mycophenolate mofetil. Literature data on the existence and significance of drug-drug interaction of these twodru